Presence of comorbid DE in the setting of remission schizophrenia seems to be closely related to more frequent excitement/hostility symptoms and a shortened remission time, besides its association with metabolic risk factors, childhood emotional abuse, comorbid depression and poor sleep quality. Screening for DE in patients with schizophrenia, regardless of the phase, seems to be of critical importance to prevent adverse outcomes of unrecognized DE on physical, emotional and mental well-being of patients during the entire course of disease.
Aytaç et al. (Sun,) studied this question.